Working… Menu

A Evaluation of the Safety of Oncocort IV Pegylated Liposomal Dexamethasone Phosphate in Patients With Progressive Multiple Myeloma (AMETHYST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03033316
Recruitment Status : Terminated (Patient enrolment issues)
First Posted : January 26, 2017
Last Update Posted : November 6, 2020
University Hospital, Aachen
Information provided by (Responsible Party):
Enceladus Pharmaceuticals BV

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2020
Actual Study Completion Date : August 2020